Back to Trades
Sell4
Emergent BioSolutions Inc.
EBS
Total Value
$650.8K
Net $263.1K sold
Sales
$263.1K
2 transactions
Company Information
- Company Name
- Emergent BioSolutions Inc.
- Ticker Symbol
- EBS
- CIK
- 0001367644
Insider Information
- Name
- Richard Ronald
- Role
- Director
- Location
- GAITHERSBURG, MD
Director
Filing Details
- Filing Date
- Dec 9, 2025
- Transaction Date
- Dec 5, 2025
- Accession Number
- 0001380177-25-000006
- Form Type
- 4
- Net Trading Amount
- -$263.1K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Common Stock | 7,100 | $12.11 | Sale | $86.0K |
| Dec 5, 2025 | Common Stock | 25,748 | $5.02 | Exercise | $129.3K |
| Dec 5, 2025 | Common Stock | 10,864 | $11.90 | Tax Withholding | $129.3K |
| Dec 5, 2025 | Common Stock | 14,884 | $11.90 | Sale | $177.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Derivative | 25,748 | $5.02 | Exercise | $129.3K |
Footnotes
- (F1)Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- (F2)The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12.
- (F3)Represents shares of common stock sold solely to satisfy the option exercise price and applicable taxes associated with the option exercise.
- (F4)The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97.
- (F5)Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, as compensation for Board and Committee service. The shares underlying the options exercised were fully vested on May 22, 2025.